Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Serine palmitoyltransferase long chain base subunit 1 pseudogene 2 (SPTLC1P2)
- Target
- SPTLC1P2
- Molecular classification
- Other (Pseudogene)
01
Overview
SPTLC1P2 is a pseudogene related to serine palmitoyltransferase long chain base subunit 1 (SPTLC1). Pseudogenes are non-functional DNA segments bearing close homology to their parent genes but are typically unable to encode a functional protein due to accumulated disabling mutations such as premature stop codons or frameshifts[11][5][10]. While some pseudogenes may have regulatory roles (for example, by acting as miRNA decoys or producing non-coding RNAs that can modulate gene expression[5][11]), there is no direct evidence that SPTLC1P2 has a biological function or disease association. It is not a therapeutic target, nor does it interact with drugs or serve as a clinically validated biomarker.
- Other names
- SPTLC1P2SPTLC1 pseudogene 2serine palmitoyltransferase long chain base subunit 1 pseudogene 2
02
Mechanism of action
None (not a drug target; no mechanism of action for drugs based on this pseudogene)
03
Biological functions
Regulation of gene expression through potential miRNA decoy activity, as described for other pseudogenes; however, there is no direct evidence for SPTLC1P2 itself
04
Disease associations
Other (Pseudogenes may act as regulators in disease by influencing gene expression, but no specific disease association is reported for SPTLC1P2)
Beyond the preview
Go deeper on Serine palmitoyltransferase long chain base subunit 1 pseudogene 2 (SPTLC1P2).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Serine palmitoyltransferase long chain base subunit 1 pseudogene 2 (SPTLC1P2).